Embolic Protection Device Market Size And Forecast Report 2024-2032

Embolic Protection Device Market Size

The global market size of embolic protection devices was estimated to be USD 1.12 billion in 2023. It is predicted to grow to about US$2.11 billion by 2032, reflecting a compound annual growth rate (CAGR) of 7.29 percent from 2024 to 2032. Some drivers propelling the market include a higher prevalence of cardiovascular diseases, increased awareness of minimally invasive procedures, and advancements in medical technology.

Embolic Protection Device Market Overview

An Embolic Protection Device (EPD) is a specialized medical tool used during cardiovascular procedures, particularly in interventions like carotid artery stenting and transcatheter aortic valve replacement (TAVR). The device is designed to capture and remove debris (emboli) that may dislodge during these procedures, preventing them from traveling to critical areas, such as the brain, where they could cause a stroke. EPDs typically include filters or occlusion balloons that trap debris while allowing continuous blood flow, enhancing patient safety and reducing complications.

Request a free sample copy of the report: https://www.renub.com/embolic-protection-device-market-p.php

Globally, embolic protection devices have grown due to the increasing prevalence of cardiovascular diseases and the rising number of minimally invasive surgeries. These devices are widely adopted in regions with advanced healthcare systems, such as North America and Europe. Emerging markets in Asia-Pacific are also seeing increased adoption as awareness of their benefits grows. EPDs are becoming a standard component of high-risk cardiovascular procedures, contributing to better patient outcomes worldwide.

Key growth factors driving the Embolic Protection Device (EPD) industry

Rising Incidence of Cardiovascular Diseases

The growing prevalence of cardiovascular diseases (CVDs), including conditions like atherosclerosis and carotid artery disease, is a significant driver for the EPD market. As the global population ages and risk factors like sedentary lifestyles, smoking, and obesity increase, the incidence of CVDs continues to rise. This has led to a surge in cardiovascular interventions such as carotid artery stenting and TAVR, where EPDs are crucial for preventing complications like strokes. With CVDs being a leading cause of death worldwide, the demand for devices that enhance the safety and efficacy of these procedures is growing, fueling the expansion of the EPD industry.

Advancements in Minimally Invasive Surgery

Technological advancements in minimally invasive cardiovascular procedures have driven the need for embolic protection devices. As techniques like transcatheter aortic valve replacement (TAVR) and percutaneous coronary interventions (PCI) become more common, the importance of embolic protection to prevent stroke and other complications has grown. Innovations in device design, such as improved filter technologies and better delivery systems, have made EPDs more effective and easier to use. These advancements have increased the adoption of EPDs in various procedures, leading to better patient outcomes. As healthcare providers increasingly prefer minimally invasive treatments, the EPD market is experiencing sustained growth.

Growing Adoption in Emerging Markets

The expanding healthcare infrastructure in emerging markets contributes to the EPD industry's growth. Countries in Asia-Pacific, Latin America, and the Middle East are witnessing increased investments in healthcare, leading to greater access to advanced cardiovascular procedures. As awareness of embolic protection devices rises and healthcare providers in these regions adopt newer technologies, the demand for EPDs is growing. Additionally, increasing disposable incomes and better access to insurance are enabling more patients to afford high-quality care, including procedures incorporating EPDs. This increasing adoption in emerging markets is a key factor driving the industry's global expansion.

North American Embolic Protection Device Market Overview:

The North American Embolic Protection Device (EPD) market is experiencing steady growth, driven by the increasing prevalence of cardiovascular diseases and the rising number of minimally invasive procedures. The region’s aging population, combined with lifestyle-related risk factors like obesity and smoking, has led to a surge in cardiovascular interventions such as carotid artery stenting and transcatheter aortic valve replacement (TAVR), where EPDs play a crucial role in preventing stroke and other complications.

The presence of advanced healthcare infrastructure and high healthcare spending support the widespread adoption of these devices in the U.S. and Canada—continuous technological advancements, such as developing more efficient and user-friendly EPDs, further fuel market growth. Additionally, robust regulatory frameworks and the presence of leading medical device manufacturers drive innovation and product availability. As awareness of the benefits of EPDs grows, the North American market is poised for continued expansion.

Embolic Protection Device Market Company Overview

Some of the industry leaders in the Global Embolic Protection Device Market Include Abbott Laboratories, Allium Medical Solutions Ltd., Boston Scientific Corporation, Cardinal Health Inc., Edwards Lifesciences Corporation, Medtronic Inc., and Silk Road Medical Inc.

Embolic Protection Device Market News

In September 2023, Following regulatory approval, Penumbra and Asahi Intecc announced that they would collaborate to bring Penumbra's Indigo aspiration system to the Japanese market. The system treats pulmonary embolism and removes thrombi and emboli from venous and peripheral arterial systems.

In January 2023, Cardinal Health Inc. partnered with Palantir to create an innovative healthcare supply chain solution. This collaboration aims to revolutionize healthcare organizations' distribution and inventory systems.

Related Report:

Global 4K Medical Imaging Market: https://www.renub.com/4k-medical-imaging-market-p.php

Global Atherectomy Devices Market: https://www.renub.com/atherectomy-devices-market-p.php

Embolic Protection Device Market: https://www.renub.com/embolic-protection-device-market-p.php

Product – Market breakup in 3 viewpoints:

Distal Filter Devices
Distal Occlusion Devices
Proximal Occlusion Devices

Application – Market breakup in 3 viewpoints:

Coronary Artery Treatment
Carotid Artery Treatment
Others

Procedure– Market breakup in 5 viewpoints:

Percutaneous Coronary Intervention
Carotid Artery Stenosis
Saphenous Vein Graft Intervention
Aortic Valve Stenosis (Transcatheter Aortic Valve Replacement)
Others

Material – Market breakup in 2 viewpoints:

Nitinol
Polyurethane

Usage – Market breakup in 2 viewpoints:

Disposable Devices
Re-Usable Devices

End User – Market breakup in 3 viewpoints:

Hospitals and Clinics
Ambulatory Surgical Centers
Others

Country – Market breakup in 25 viewpoints:

North America

United States
Canada

Europe

France
Germany
Italy
Spain
United Kingdom
Belgium
the Netherlands
Turkey

Asia Pacific

China
Japan
India
Australia
South Korea
Thailand
Malaysia
Indonesia
New Zealand

Latin America

Brazil
Mexico
Argentina

Middle East Africa

South Africa
Saudi Arabia
United Arab Emirates

All the Key players have been covered from 4 Viewpoints:

Overviews
Recent Developments Strategies
Product Portfolio Product Launch in Last 1 Year
Revenue

Company Analysis:

Abbott Laboratories
Allium Medical Solutions Ltd.
Boston Scientific Corporation
Cardinal Health Inc.
Edwards Lifesciences Corporation
Medtronic Inc.
Silk Road Medical Inc.

About the Company:

Renub Research is a Market Research and Information Analysis company with more than 15 years of experience in Research, Survey, and Consulting. Our research helps companies to take business decisions: on strategy, organization, operations, technology, mergers acquisitions, etc. Till now we have published more than 9000 syndicated reports and worked on more than 750 custom research projects. Currently, we are supplying data to EMIS, Bloomberg, Thomson Reuters, etc. We support many blue-chip companies by providing them with findings and perspectives across a wide range of markets.